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Abstract 
 
Venous thromboembolism has a strong association with pelvic malignancy, whereby a failure in recognizing this 
event will lead to mortality. The best intervention depends on the individual basis with the availability of supporting 
service. We illustrate a case of gynaecological malignancy with concurrent deep vein thrombosis undergoing staging 
laparotomy and debulking surgery. Inferior vena cava filter was inserted after initial thrombolytic therapy and 
subsequently a long term treatment. Death from massive pulmonary embolism and major bleeding was prevented 
and synchronous primary ovarian and endometrial cancer prognosis was reassured in this case. 
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Introduction 
 
Virchows’ triad explains the pathogenesis of venous 
thromboembolism, contributed by hypercoagulability 
state, endothelial damage and venous stasis. The 
association between malignancy and venous 
thromboembolism is well known as the malignant cells 
can promote thrombus formation through the same 
mechanism (1). Tumour cells activate the clotting 
system directly by generating thrombin production and 
indirectly by stimulating mononuclear cell to produce 
and express pro-coagulant substance. All these factors 
ultimately resulting to hypercoagulability state leading 
to thrombosis.  More so, immobility and extrinsic 
venous compression by the tumour results to stasis of 
the venous blood flow. Direct vascular invasion of the 
tumour cells together with direct injury from extrinsic 
factor such as venous catheter or chemotherapy can 
lead to endothelial damage.  
 
Ovarian tumour with underlying deep vein thrombosis 
poses a great dilemma in optimal management, 
without jeopardizing patients’ well beings. Such a 
patient is at high risk of pulmonary embolism 
especially during surgery causing mortality and thus 
would require anticoagulant. Treating the deep vein 
thrombosis with anticoagulant to reduce the size of the 
thrombus and the risk of embolism would delay the 
optimal debulking surgery, lead to a poorer prognosis. 
Even, there is an option of neoadjuvant chemotherapy 
in an inoperable disease, but staging laparotomy and 
debulking is still the mainstay of definitive treatment 
especially in apparent early stage disease. 
 
Patients on anticoagulant at the time of surgery are 
also at risk of increased intra-operative blood loss and 
possible need of blood transfusion and mortality. 
There are scarce evidence on the optimal care in such 
cases and lack of case reports discussing on personal 
experience in handling this problematic cases.   
 
Case report 
Inferior vena cava filter in deep vein thrombosis   Shafiee MN et al. 
65 
 
Case report  
 
A 41-year-old, single nulliparous lady, presented with 
prolonged, heavy menstrual bleeding associated with 
abdominal distension two months prior to the 
admission. Assessment revealed a suprapubic mass 
equivalent to 22 weeks sized uterus. It was well 
defined margin with solid and cystic in consistency 
and restricted mobility with no ascites or 
hepatosplenomegaly. Incidentally, she was noted to 
have a swollen and tender left leg and a Doppler flow 
study confirmed distal femoral and popliteal vein 
thrombosis.  
 
A pelvic ultrasound scan revealed a left adnaexal mass 
measuring 14.2 x15.5 x19.2 cm, multiloculated with 
solid and cystic appearance. The right ovary was 
normal in size and minimal free fluid noted at cul-de-
sac. The uterine size was 8.4 x5.2 cm with endometrial 
thickness of 18 mm. An abdominal and pelvic 
computed tomography (CT) scan further confirmed the 
findings and there were no peritoneal nodules or 
lymphadenopathy noted. Serum CA 125 level was 
significantly raised to 1782 IU/ml.  
 
A temporary inferior vena cava (IVC) filter was 
inserted following two days of therapeutic 
anticoagulation with heparin. A staging laparotomy 
and tumour debulking was then performed on the 
following day and a left ovarian tumour measuring 
15x15cm with bulky uterus and minimal ascites was 
found. An optimal debulking which includes total 
hysterectomy with bilateral salpingo-oophorectomy, 
omentectomy and pelvic lymphadenectomy was 
performed following peritoneal washing for cytology. 
The IVC filter was kept untill three weeks 
postoperatively while warfarinization continued for the 
next six months.  
 
The pathological examination revealed an interesting 
finding. Even with negative peritoneal fluid cytology 
for malignancy, no evidence of myometrial invasion or 
lymphovascular space infiltration, both endometrium 
and ovary demonstrate a similar pattern of 
proliferative type endometrial glands, with nuclear 
stratification and papillary growth. Hence, it was 
unlikely metastasis of ovarian cancer to endometium 
or vice-versa. A diagnosis of synchronous primary 
ovarian and endometrial cancer was made with 
difficulty. 
 
Following surgery, she received six cycles of adjuvant 
chemotherapy, a combination of carboplatin and 
paclitaxel with no evidence of tumour recurrence. 
 
 
Discussion 
 
Management of deep vein thrombosis in patient 
requiring surgery is difficult. Issues related to this case 
include risk of massive pulmonary embolism causing 
death, bleeding at surgery due to thrombolytic agent 
used and delaying treatment leading to possible distant 
metastasis. In general, there are three options to 
combat risk of pulmonary embolism in such patient 
which include preoperative anticoagulation, 
preoperative inferior vena cava (IVC) filter insertion 
or intraoperative IVC ligation. This case highlights an 
optimal outcome following IVC filter insertion before 
major gynaecological surgery. This intervention is 
relatively new and Cohen et al reported a low 
complication rate with good outcome to those 
receiving this intervention (2). 
 
The standard treatment for deep vein thrombosis is 
still five to ten days of heparinization either 
unfractionated or low molecular weight heparin 
followed by three to six months of anticoagulant using 
warfarin (3). Studies show that low molecular weight 
heparin was an effective and convenient alternative to 
intravenous heparin (3).  The problem with heparin 
compared to IVC filter is that it delays surgical 
intervention and thus could affect the prognosis of the 
patient. Furthermore it is less effective in the presence 
of extrinsic mass compression and it induces 
thrombocytopenia which would result in further 
intraoperative blood loss. Hoffman et al reviewed all 
the three options and recommended that therapeutic 
heparinization and preoperative placement of IVC 
filter should be offered to almost all gynaecological 
malignancy patients with venous thrombosis (4). 
 
Conclusion 
 
IVC filter is relatively new and reliable modality in 
preventing pulmonary embolism in patient with 
venous thrombosis before undergoing staging 
laparotomy and debulking. However, careful 
assessment is mandatory in weighing the benefit of 
this invasive procedure especially in a frail patient 
which surgery itself is not justified. 
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